Sfoglia per AUTORE
LEONE F
Collezione ASL Biella

  

Items : 33

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study. in Targeted oncology / Target Oncol. 2024 May;19(3):359-370. doi: 10.1007/s11523-024-01060-1. Epub 2024 May 1.

2024
ASL Biella
AOU Città della Salute di Torino

Casadei-Gardini A; Rimassa L; Antonuzzo L; Vivaldi C; Stefano C; Foti S; Rizzato MD; De Braud F; Aldrighetti L; Ratti F; Zanuso V; De Rosa A; Niger M; Rossari F; Fornaro L; Satolli MA; Brandi G; Garattini SK; Brunetti O; Pirrone C; Leone F; Diana A; Pretta A; Toma I; Landriscina M; Lorenzo A; Gusmaroli E; Bergamo F; Balsano R; et alii...

Prognostic and predictive role of FGFR2 and IDH1 targetable alterations in advanced biliary tract cancer (aBTC): Data from the Italian ANITA dataset in Annals of Oncology

2024
ASL Biella

Genovesi V; Rimini M; Pressiani T; Soldà C; Nichetti F; Salvatore L; Antonuzzo L; Silvestro L; Diana A; Leone F; Foti S; Balsano R; Piva VM; Pircher CC; Camera S; Masi G; Rimassa L; De Grandis MC; Gardini AC; Fornaro L;

Extended molecular profiling (EMP) and access to targeted treatment (TT) in advanced biliary tract cancer (BTC): Results from the Italian cholangiocarcinoma dataset (ANITA) in Annals of Oncology

2024
ASL Biella

Genovesi V; Rimini M; Pressiani T; Rizzato MD; Niger M; Salvatore L; Antonuzzo L; Silvestro L; Diana A; Leone F; Salani F; Foti S; Zanuso V; De Rosa A; Pircher CC; Vivaldi C; Rimassa L; Sperotto S; Casadei Gardini A; Fornaro L;

Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice. in Cancers / Cancers (Basel). 2023 Jan 31;15(3):900. doi: 10.3390/cancers15030900.

2023
ASL Biella
AO Cuneo

Masi G; Aprile G; Fornaro L; De Manzoni G; Basile D; Bencivenga M; Vasile E; Leone F; Montagnani F; Puzzoni M; Scartozzi M; Ribero D; Vivaldi C; Fanotto V; Salani F;

Fluoropyrimidine?induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT). in Oncology reports / Oncol Rep. 2023 Feb;49(2):31. doi: 10.3892/or.2022.8468. Epub 2022 Dec 23.

2023
AOU Città della Salute di Torino
ASL Biella

Leone F; Aglietta M; Ostano P; Chiorino G; Cavalloni G; Gammaitoni L; Basiricò M; Cagnazzo C; Milanesio M; Quarà V; Filippi R; Fenocchio E; Depetris I; Bonzano A; Peraldo-Neia C; Aimar G; Lombardi P;

Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy. in Frontiers in oncology / Front Oncol. 2023 Apr 5;13:1128930. doi: 10.3389/fonc.2023.1128930. eCollection 2023.

2023
ASL Biella
AOU Città della Salute di Torino

Fornaro L; Aprile G; Lonardi S; Rizzo A; Aglietta M; Satolli MA; Faloppi L; Santini D; Silvestris N; Brandi G; Scartozzi M; Leone F; Casadei-Gardini A;

Modified FOLFOXIRI plus cetuximab and avelumab as initial therapy in RAS wild-type unresectable metastatic colorectal cancer: Results of the phase II AVETRIC trial by GONO in Annals of Oncology

2023
ASL Biella

Conca V; Antoniotti C; Bergamo F; Pietrantonio F; Rossini D; Scartozzi M; Perissinotto E; Leone A; Pusceddu V; Borelli B; Cavanna L; Latiano T; Santini D; Masi G; Salvatore L; Frassineti G; Leone F; Tamberi S; Boni L; Cremolini C;

A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index. in Journal of gastrointestinal cancer / J Gastrointest Cancer. 2022 Sep;53(3):528-536. doi: 10.1007/s12029-021-00649-3. Epub 2021 May 25.

2022
ASL Biella
AO Ordine Mauriziano
AOU Città della Salute di Torino

Casadei-Gardini A; Cascinu S; Burgio V; Aprile G; De Lorenzo S; Sperti E; Massa V; De Braud F; Jeong JH; Iacono D; Pircher C; Cho H; Lai E; Fenocchio E; Bernardini L; Aglietta M; Palloni A; Faloppi L; Silvestris N; Santini D; Filippi R; Casagrande M; Yoo C; Niger M; Scartozzi M; Cesario S; Brandi G; Rovesti G; Leone F; et alii...

Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index. in Journal of gastrointestinal cancer / J Gastrointest Cancer. 2022 Jun;53(2):289-298. doi: 10.1007/s12029-021-00596-z. Epub 2021 Feb 5.

2022
ASL Biella
AO Ordine Mauriziano
AOU Città della Salute di Torino

Casadei-Gardini A; Cascinu S; Orsi G; Aprile G; Di Maio M; Jeong JH; de Braud F; Vasile E; De Lorenzo S; Pella N; Fenocchio E; Nichetti F; Lai E; Cho H; Vivaldi C; Aglietta M; Faloppi L; Palloni A; Santini D; Silvestris N; Casagrande M; Filippi R; Scartozzi M; Niger M; Yoo C; Caputo F; Fornaro L; Brandi G; Rovesti G; et alii...

Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles. in Human genomics / Hum Genomics. 2022 Dec 20;16(1):70. doi: 10.1186/s40246-022-00436-6.

2022
ASL Biella

Di Leone A; Chiorino G; Masetti R; Scatolini M; Magno S; Carlino A; Maggiore C; Guarino D; Mulè A; Santoro A; Liscia D; Leone F; Laurora S; Crivelli F; Gregnanin I; Mello-Grand M; Akhouayri L; Ostano P;

Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2022 Dec;34(8):543-549. doi: 10.1080/1120009X.2022.2036557. Epub 2022 Feb 14.

2022
ASL Biella
AOU Città della Salute di Torino
AO Ordine Mauriziano

Aldrighetti L; Sperti E; Burgio V; Ratti F; Cucchetti A; Cascinu S; Faloppi L; Pellino A; Salani F; Scartozzi M; Vivaldi C; Satolli MA; Fenocchio E; Aprile G; Frega G; Aglietta M; Santini D; Palloni A; Filippi R; Masi G; Galizia E; Silvestris N; Montagnani F; Lonardi S; Lai E; Fornaro L; Pella N; Leone F; Brandi G; et alii...

Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2022 Apr;34(2):123-132. doi: 10.1080/1120009X.2021.1953887. Epub 2021 Jul 27.

2022
ASL Biella
AOU Città della Salute di Torino

Brandi G; Aglietta M; Fenocchio E; Brunetti O; Vivaldi C; Spadi R; Giulia O; Frega G; Garattini SK; Lombardi P; Lutrino SE; Russano M; Scartozzi M; Satolli MA; Silvestris N; Palloni A; Filippi R; Leone F; Casadei-Gardini A; Aprile G; Fornaro L;

Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma. in Frontiers in oncology / Front Oncol. 2022 Feb 17;12:771418. doi: 10.3389/fonc.2022.771418. eCollection 2022.

2022
ASL Biella

Cavalloni G; Marchiò S; Leone F; Sarotto I; Bernabei P; Erriquez J; Basiricò M; Raggi C; Peraldo-Neia C; Vita F; Aglietta M; Varamo C; Massa A;

A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy. in Acta oncologica (Stockholm, Sweden) / Acta Oncol. 2021 Oct;60(10):1317-1324. doi: 10.1080/0284186X.2021.1953704. Epub 2021 Jul 20.

2021
ASL Biella
AOU Città della Salute di Torino

Leone F; Brandi G; Rovesti G; Aglietta M; Rimini M; Silvestris N; Vivaldi C; Citarella F; Lutrino SE; Scartozzi M; Palloni A; Satolli MA; Casadei-Gardini A; Faloppi L; Aprile G; Fornaro L; Lombardi P; Filippi R; Montagnani F;

Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients. in BMC cancer / BMC Cancer. 2021 Jul 28;21(1):865. doi: 10.1186/s12885-021-08576-z.

2021
ASL Biella
AO Ordine Mauriziano

Leone F; Cervellati C; Ciccosanti F; Trentini A; De Rosa G; Daniele L; Massa A; Bergamini C; Aglietta M; Cavalloni G; Peraldo-Neia C;

A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient. in Cancers / Cancers (Basel). 2021 Apr 23;13(9):2051. doi: 10.3390/cancers13092051.

2021
ASL Biella

Cavalloni G; Aglietta M; Leone F; Panero M; Casorzo L; Ostano P; Basiricò M; Bernabei P; Raggi C; Vita F; Massa A; Peraldo-Neia C;

Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients. in Oncology / Oncology. 2021;99(5):292-299. doi: 10.1159/000512796. Epub 2021 Feb 24.

2021
AO Ordine Mauriziano
ASL Biella
AOU Città della Salute di Torino

Cascinu S; Quarà V; Leone F; Giovannelli F; Cesario S; Frassineti GL; Fenocchio E; Argentiero A; Valgiusti M; Bernardini L; Ratti F; Andrikou K; La Face R; Vivaldi C; Brunetti O; Sperti E; Bartolini G; Rovesti G; Aimar G; Aldrighetti L; Silvestris N; Fornaro L; Rapposelli IG; Rimini M; Filippi R; Casadei-Gardini A;

1857P Choose health, oncological patients centered exercise (CHOiCE): Preliminary findings of a pilot randomized controlled trial in Annals of Oncology

2021
ASL Biella

Milella M; Lanza M; Pilotto S; Leone F; Valentini M; Menis J; Belluomini L; Riva ST; Trestini I; Tregnago D; Scrivano G; Avancini A;

A novel multidrug?resistant cell line from an italian intrahepatic cholangiocarcinoma patient in Cancers

2021
ASL Biella

Peraldo?neia C; Massa A; Vita F; Basiricò M; Raggi C; Bernabei P; Ostano P; Casorzo L; Panero M; Leone F; Cavalloni G; Aglietta M;

A novel multidrug?resistant cell line from an italian intrahepatic cholangiocarcinoma patient in Cancers

2021
ASL Biella

Peraldo?neia C; Massa A; Vita F; Basiricò M; Raggi C; Bernabei P; Ostano P; Casorzo L; Panero M; Leone F; Cavalloni G; Aglietta M;

Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial. in ESMO open / ESMO Open. 2020 Sep;5(5):e000911. doi: 10.1136/esmoopen-2020-000911.

2020
ASL Biella

Siena S; Bardelli A; Trusolino L; Marsoni S; Cappello G; Regge D; Sapino A; Vanzulli A; Torri V; Bonoldi E; Grassi E; Amatu A; Bencardino K; Valtorta E; Ardizzoni A; Ciardiello F; Zagonel V; Bergamo F; Leone F; Martino C; Fenocchio E; Ghezzi S; Tosi F; Lonardi S; Sartore-Bianchi A;

The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2020 Mar;40(3):704-711. doi: 10.1111/liv.14314. Epub 2019 Dec 11.

2020
ASL Cuneo 2
ASL Biella
AOU Città della Salute di Torino
AO Ordine Mauriziano

Casadei-Gardini A; Aprile G; Roviello G; Scartozzi M; Cascinu S; Silvestris N; Spallanzani A; Santini D; Gelsomino F; Depetris I; Cagnazzo C; Lombardi P; Fenocchio E; Sperti E; Di Maio M; Ortega C; Fornaro L; Aglietta M; Leone F; Cerma K; Salani F; Caputo F; Vivaldi C; Filippi R; Salati M;

Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes. in The oncologist / Oncologist. 2020 Jun;25(6):481-487. doi: 10.1634/theoncologist.2019-0611. Epub 2020 Jan 22.

2020
ASL Biella

Fassan M; Zagonel V; Lonardi S; Nguyen A; Schirripa M; Sanborn JZ; Dei Tos AP; Golovato J; Rugge M; Salmaso R; Munari G; Zapata L; Sottoriva A; Valeri N; Bonetti LR; Maddalena G; Cascinu S; Spallanzani A; Leone F; Lombardi P; Filippi R; Prete AA; Biason P; Intini R; Depetris I; Loupakis F;

Radiomics predicts response of individual HER2-amplified colorectal cancer liver metastases in patients treated with HER2-targeted therapy. in International journal of cancer / Int J Cancer. 2020 Dec 1;147(11):3215-3223. doi: 10.1002/ijc.33271. Epub 2020 Sep 14.

2020
ASL Cuneo 2
ASL Cuneo 1
ASL Biella

Regge D; Vanzulli A; Siena S; Marsoni S; Zagonel V; Leone F; Torresin A; Sartore-Bianchi A; De Mattia C; Rizzetto F; Vassallo L; Cappello G; Mazzetti S; Balestra G; Defeudis A; Rosati S; Giannini V;

Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer. in Clinical colorectal cancer / Clin Colorectal Cancer. 2020 Dec;19(4):256-262.e2. doi: 10.1016/j.clcc.2020.06.009. Epub 2020 Jun 27

2020
ASL Biella

Marsoni S; Trusolino L; Zagonel V; Bardelli A; Regge D; Ciardiello F; Cassingena A; Cappello G; Bonoldi E; Vanzulli A; Marrapese G; Valtorta E; Mauri G; Torri V; Siravegna G; Troiani T; Martinelli E; Bonazzina E; Fenocchio E; Bergamo F; Bencardino K; Amatu A; Leone F; Ghezzi S; Martino C; Siena S; Tosi F; Sartore-Bianchi A; Lonardi S; et alii...

SARS-CoV-2 infection among cancer patients receiving antitumor treatment in Italy: A nationwide observational study (CIPOMO ONCO COVID-19) in Annals of Oncology

2020
ASL VCO
ASL Biella

Negru ME; Tondini C; Pastorino A; Caccese M; Cariello A; Bertolini A; Buzzatti G; Cinieri S; Comandone A; Grossi F; Franchini M; Caffo O; Garrone O; Mambrini A; Leone F; Chini C; Agustoni F; Artioli F; Blasi L; Aschele C;

Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer? in Cancers / Cancers (Basel). 2019 Oct 12;11(10):0. doi: 10.3390/cancers11101547.

2019
ASL Biella
ASL Città di Torino

Aglietta M; Leone F; Aimar G; Milanesio M; Quarà V; Filippi R; Lombardi P; Fenocchio E;

Assessment of a High Sensitivity Method for Identification of IDH1 R132x Mutations in Tumors and Plasma of Intrahepatic Cholangiocarcinoma Patients. in Cancers / Cancers (Basel). 2019 Mar 30;11(4):454. doi: 10.3390/cancers11040454.

2019
ASL Biella

Peraldo-Neia C; Scatolini M; Grosso E; Lombardi P; Filippi R; Raggi C; Marchiò C; Cavalloni G; Aglietta M; Leone F;

Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives. in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2019 Dec;20(17):2121-2137. doi: 10.1080/14656566.2019.1667335. Epub 2019 S

2019
ASL Biella
ASL Città di Torino

Leone F; Aimar G; Milanesio M; Fenocchio E; Lombardi P; Quarà V; Aglietta M; Filippi R;

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan. in Clinical colorectal cancer / Clin Colorectal Cancer. 2019 Dec;18(4):e394-e401. doi: 10.1016/j.clcc.2019.08.004. Epub 2019 Sep 4.

2019
ASL Biella
ASL VCO
AOU Città della Salute di Torino
AO Ordine Mauriziano

Buscaglia P; Meurisse A; Passardi A; Pasquini G; Aglietta M; Clerico M; Falcone A; Neuzillet C; Spadi R; Edeline J; Satolli MA; Musettini G; Vernerey D; Sperti E; De Luca E; Lombardi P; Vivaldi C; Lièvre A; Casadei-Gardini A; Vienot A; Leone F; Fornaro L; Brac C; Vasile E; Montagnani F;

Fluoropyrimidine-induced cardiotoxicity in colorectal cancer patients: Preliminary data from the prospective observational CHECKPOINT trial (NCT02665312) in Annals of Oncology

2019
ASL Biella

Lombardi P; Aimar G; Depetris I; Bonzano A; Filippi R; Fenocchio E; Quarà V; Milanesio M; Ferraris R; Cagnazzo C; Neia CP; Basiricò M; Cavalloni G; Aglietta M; Leone F;

Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2017 Sep;83:106-115. doi: 10.1016/j.ejca.2017.06.029. Epub 2017 Jul 20.

2017
ASL Biella

Galli F; Ronzoni M; Scartozzi M; Labianca R; Ferraú F; Giordano M; Corsi DC; Zagonel V; Bilancia D; Iaffaioli RV; Leone F; Zaniboni A; Marchetti P; Lonardi S; Rosati G; Nasti G; Cascinu S;

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer in Annals of Oncology

2014
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 2

Bajetta E; Floriani I; Di Bartolomeo M; Labianca R; Falcone A; Di Costanzo F; Comella G; Amadori D; Pinto C; Carlomagno C; Nitti D; Daniele B; Mini E; Poli D; Santoro A; Mosconi S; Casaretti R; Boni C; Pinotti G; Bidoli P; Landi L; Rosati G; Ravaioli A; Cantore M; Di Fabio F; Aitini E; Marchet A; Rulli E; Cropalato Di Tullio M; et alii...